Cardio- and cerebrovascular safety of erenumab, a monoclonal antibody targeting CGRP receptors – important studies on human isolated arteries

Meßlinger K, Maassen van den Brink A (2019)

Publication Type: Journal article

Publication year: 2019

Journal

Cephalalgia Sage Publications

DOI: 10.1177/0333102419877169

Authors with CRIS profile

Karl Meßlinger Professur für Zelluläre und Molekulare Neurophysiologie

Involved external institutions

Erasmus University Medical Center (MC) NL Netherlands (NL)

How to cite

APA:

Meßlinger, K., & Maassen van den Brink, A. (2019). Cardio- and cerebrovascular safety of erenumab, a monoclonal antibody targeting CGRP receptors – important studies on human isolated arteries. Cephalalgia. https://doi.org/10.1177/0333102419877169

MLA:

Meßlinger, Karl, and Antoinette Maassen van den Brink. "Cardio- and cerebrovascular safety of erenumab, a monoclonal antibody targeting CGRP receptors – important studies on human isolated arteries." Cephalalgia (2019).

BibTeX: Download